Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K H Rahn

Showing results (51-60 of 217) with videos related to

Pageof 22
Sort By:
Zeitschrift Fur Kardiologie|January 1, 1994
[Cost/benefit relations: therapy of hypertension]K H Rahn, H Hohage
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1972
[Influence of the antihypertensive agent guanethidine (ismelin) on excretion of vanillin mandelic acid in the urine of hypertensive patients]K H Rahn, P Bohr
Der Internist|October 1, 1992
[Diuretics. Range of effect, indications and therapeutic results in heart diseases]W Zidek, K H Rahn
Kidney & Blood Pressure Research|October 8, 1998
Target blood pressure in the treatment of essential hypertensionK H Rahn, M Hausberg
MMW, Munchener Medizinische Wochenschrift|February 22, 1984
[Effect and tolerance of the angiotensin-converting enzyme inhibitor captopril (Tensobon)]K H Rahn, K O Stumpe
Die Medizinische Welt|June 26, 1981
[Drug withdrawal symptoms following treatment with beta-receptor blockaders]H J Gilfrich, K H Rahn
Fortschritte Der Medizin|December 10, 1998
[Is everything clear in achieving blood pressure control? Consequences from the HOT Study for treatment of hypertension in general practice. Interview by Eckhard Böttchen-Bühler]R E Kolloch, K H Rahn
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1973
[Pharmacokinetic studies in man with a beta-sympathomimetic drug used as aerosol]H W Seyberth, K H Rahn
Deutsche Medizinische Wochenschrift (1946)|February 18, 1998
[The Hypertension Optimal Treatment (HOT) study: results of 12-month therapy related to age]R E Kolloch, K H Rahn
Der Internist|January 17, 2002
[Drug therapy of arterial hypertension. Results of new intervention studies]M Hausberg, M Kosch, K H Rahn
Pageof 22

Showing results (51-60 of 217) with videos related to

Sort By:
Pageof 22
Zeitschrift Fur Kardiologie|January 1, 1994
[Cost/benefit relations: therapy of hypertension]K H Rahn, H Hohage
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1972
[Influence of the antihypertensive agent guanethidine (ismelin) on excretion of vanillin mandelic acid in the urine of hypertensive patients]K H Rahn, P Bohr
Der Internist|October 1, 1992
[Diuretics. Range of effect, indications and therapeutic results in heart diseases]W Zidek, K H Rahn
Kidney & Blood Pressure Research|October 8, 1998
Target blood pressure in the treatment of essential hypertensionK H Rahn, M Hausberg
MMW, Munchener Medizinische Wochenschrift|February 22, 1984
[Effect and tolerance of the angiotensin-converting enzyme inhibitor captopril (Tensobon)]K H Rahn, K O Stumpe
Die Medizinische Welt|June 26, 1981
[Drug withdrawal symptoms following treatment with beta-receptor blockaders]H J Gilfrich, K H Rahn
Fortschritte Der Medizin|December 10, 1998
[Is everything clear in achieving blood pressure control? Consequences from the HOT Study for treatment of hypertension in general practice. Interview by Eckhard Böttchen-Bühler]R E Kolloch, K H Rahn
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1973
[Pharmacokinetic studies in man with a beta-sympathomimetic drug used as aerosol]H W Seyberth, K H Rahn
Deutsche Medizinische Wochenschrift (1946)|February 18, 1998
[The Hypertension Optimal Treatment (HOT) study: results of 12-month therapy related to age]R E Kolloch, K H Rahn
Der Internist|January 17, 2002
[Drug therapy of arterial hypertension. Results of new intervention studies]M Hausberg, M Kosch, K H Rahn
Pageof 22